Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Clinical Research›Chemometrics
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Chemometrics

Clinical Research · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The use of statistical and mathematical methods to analyze chemical observations and phenomena, such as epidemiological analysis of spectroscopically identified bacteria or quantitative structure-activity relationship.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (741 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The use of statistical and mathematical methods to analyze chemical observations and phenomena, such as epidemiological analysis of spectroscopically identified bacteria or quantitative structure-activity relationship.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Chemometric Analysis; Analyses, Chemometric; Analysis, Chemometric; Chemometric Analyses; Chemometry.

Where it fits in the MeSH classification

Broader topics
Chemistry Techniques, Analytical; Statistics as Topic; Epidemiologic Measurements

Related concepts

  • Quantitative Structure-Activity Relationship

Research landscape

PubMed indexes 1,158 records tagged with the MeSH heading “Chemometrics” (counts retrieved 2026-10-29). 1,155 of them (99.7%) were published from 2020 onward, and the busiest period so far is 2020 onward with 1,155 records.

Reviews account for 52 records (4.5%) and meta-analyses for 0. Randomized controlled trials number 0 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 0 records; 2010-2019: 3 records; 2020 onward: 1,155 records0through 199902000-200932010-20191,1552020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-20090
2010-20193
2020 onward1,155
Share of records by publication typeReviews: 4.5 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.0 percentReviews4.5% (52)Meta-analyses0.0% (0)Randomized controlled trials0.0% (0)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,158 PubMed records
TypeRecordsShare
Reviews524.5%
Meta-analyses00.0%
Randomized controlled trials00.0%

Method: PubMed query "Chemometrics"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in clinical research

Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Application and Progress of Chemometrics in Voltammetric Biosensing
Liu J, Xu Y, Liu S, Yu S, Yu Z, Low SS
2022Review article
Design not recorded in structured metadata
30cc by
PMID 35884297 · DOI · PMC9313226
Chemometric Strategies for Fully Automated Interpretive Method Development in Liquid Chromatography
Bos TS, Boelrijk J, Molenaar SRA, van 't Veer B, Niezen LE, van Herwerden D, et al.
2022Research article
Design not recorded in structured metadata
27cc by
PMID 36318471 · DOI · PMC9685588
Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging
LaLone V, Aizenshtadt A, Goertz J, Skottvoll FS, Mota MB, You J, et al.
2023Research article
Design not recorded in structured metadata
26cc by
PMID 37159662 · DOI · PMC10162950
Pharmabiome analyses in tandem with chemometrics can help trace the provenance of falsified medicines: A proof-of-concept study
Perez-Mon C, Roncone A, Abrahim A, Islam M, Hauk C, Caillet C, et al.
2026Research article
Design not recorded in structured metadata
1cc by
PMID 41274226 · DOI · PMC7618506

Application and Progress of Chemometrics in Voltammetric Biosensing [1]

Review article Liu J, Xu Y, Liu S, Yu S, Yu Z, Low SS · · 2022 · cited 30 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The voltammetric electrochemical sensing method combined with biosensors and multi-sensor systems can quickly, accurately, and reliably analyze the concentration of the main analyte and the overall characteristics of complex samples.
Closing excerpt
Finally, smartphones connected with miniaturized voltammetric biosensors and chemometric methods provide a high-quality portable analysis platform that shows great potential in point-of-care testing.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

The voltammetric electrochemical sensing method combined with biosensors and multi-sensor systems can quickly, accurately, and reliably analyze the concentration of the main analyte and the overall characteristics of complex samples. Simultaneously, the high-dimensional voltammogram contains the rich electrochemical features of the detected substances. Chemometric methods are important tools for mining valuable information from voltammetric data. Chemometrics can aid voltammetric biosensor calibration and multi-element detection in complex matrix conditions. This review introduces the voltammetric analysis techniques commonly used in the research of voltammetric biosensor and electronic tongues. Then, the research on optimizing voltammetric biosensor results using classical chemometrics is summarized. At the same time, the incorporation of machine learning and deep learning has brought new opportunities to further improve the detection performance of biosensors in complex samples. Finally, smartphones connected with miniaturized voltammetric biosensors and chemometric methods provide a high-quality portable analysis platform that shows great potential in point-of-care testing.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35884297 · DOI · PMC9313226

Chemometric Strategies for Fully Automated Interpretive Method Development in Liquid Chromatography [2]

Research article Bos TS, Boelrijk J, Molenaar SRA, van 't Veer B, Niezen LE, van Herwerden D, et al. · · 2022 · cited 27 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The majority of liquid chromatography (LC) methods are still developed in a conventional manner, that is, by analysts who rely on their knowledge and experience to make method development decisions.
Closing excerpt
, previously published data handling algorithms).
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (197 words)

The majority of liquid chromatography (LC) methods are still developed in a conventional manner, that is, by analysts who rely on their knowledge and experience to make method development decisions. In this work, a novel, open-source algorithm was developed for automated and interpretive method development of LC(-mass spectrometry) separations ("AutoLC"). A closed-loop workflow was constructed that interacted directly with the LC system and ran unsupervised in an automated fashion. To achieve this, several challenges related to peak tracking, retention modeling, the automated design of candidate gradient profiles, and the simulation of chromatograms were investigated. The algorithm was tested using two newly designed method development strategies. The first utilized retention modeling, whereas the second used a Bayesian-optimization machine learning approach. In both cases, the algorithm could arrive within 4-10 iterations (i.e., sets of method parameters) at an optimum of the objective function, which included resolution and analysis time as measures of performance. Retention modeling was found to be more efficient while depending on peak tracking, whereas Bayesian optimization was more flexible but limited in scalability. We have deliberately designed the algorithm to be modular to facilitate compatibility with previous and future work (e.g., previously published data handling algorithms).

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36318471 · DOI · PMC9685588

Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging [3]

Research article LaLone V, Aizenshtadt A, Goertz J, Skottvoll FS, Mota MB, You J, et al. · · 2023 · cited 26 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Confocal Raman spectral imaging (RSI) enables high-content, label-free visualization of a wide range of molecules in biological specimens without sample preparation.
Closing excerpt
Quantitative chemometric phenotyping constitutes an important step in developing quantitative label-free interrogation of 3D biological specimens.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (128 words)

Confocal Raman spectral imaging (RSI) enables high-content, label-free visualization of a wide range of molecules in biological specimens without sample preparation. However, reliable quantification of the deconvoluted spectra is needed. Here we develop an integrated bioanalytical methodology, qRamanomics, to qualify RSI as a tissue phantom calibrated tool for quantitative spatial chemotyping of major classes of biomolecules. Next, we apply qRamanomics to fixed 3D liver organoids generated from stem-cell-derived or primary hepatocytes to assess specimen variation and maturity. We then demonstrate the utility of qRamanomics for identifying biomolecular response signatures from a panel of liver-altering drugs, probing drug-induced compositional changes in 3D organoids followed by in situ monitoring of drug metabolism and accumulation. Quantitative chemometric phenotyping constitutes an important step in developing quantitative label-free interrogation of 3D biological specimens.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 37159662 · DOI · PMC10162950

Pharmabiome analyses in tandem with chemometrics can help trace the provenance of falsified medicines: A proof-of-concept study [4]

Research article Perez-Mon C, Roncone A, Abrahim A, Islam M, Hauk C, Caillet C, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
A lack of robust analytical approaches limits our ability to investigate the clandestine manufacturing origins of falsified medicines.
Closing excerpt
Collectively, our research provides experimental support for the development of integrated, multifaceted tools for tracing the origin of falsified medicines, advancing efforts to combat this pervasive but neglected global health problem.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (267 words)

A lack of robust analytical approaches limits our ability to investigate the clandestine manufacturing origins of falsified medicines. We conducted a proof-of-concept study to test the feasibility of geolocating the production sites of falsified medicines, based on the identification of site-specific biological and chemo-isotopic features using a combination of environmental DNA metabarcoding, Direct Analysis in Real Time - Mass Spectrometry and Isotope Ratio Mass Spectrometry as profiling techniques. We produced tablets at two distant locations (England vs. Thailand), using controlled manufacturing methods, excipient composition and environmental conditions. Sets of tablets produced at separate locations showed distinct bacterial and eukaryotic diversity, particularly influenced by the incorporation of water used during tableting and the background environmental biosignatures of the production site. Tablets showed corresponding site-specific chemometric profiles, but the factors contributing to the observed chemical differences were unclear. When reference samples of known origin are available, our study suggests that site-specific biological and chemical features can be used in modelling approaches to successfully predict product origin. We developed a new mapping approach to exploit the geographic information within the eukaryotic pharmabiome of the falsifications; based on eDNA-derived species identification and the integration of publicly available species distribution data. In the absence of reference samples of known origin, the application of this workflow to our dataset provided partial clues about the product's origin, with limitations likely due to taxonomic resolution and the presence of species with wide distribution ranges. Collectively, our research provides experimental support for the development of integrated, multifaceted tools for tracing the origin of falsified medicines, advancing efforts to combat this pervasive but neglected global health problem.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41274226 · DOI · PMC7618506

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Chemometric analysis in Raman spectroscopy from experimental design to machine learning-based modeling [5]
    Guo S, Popp J, Bocklitz T · Nat Protoc · 2021 · cited 222 times (Europe PMC)
  • Research article A comprehensive overview of emerging techniques and chemometrics for authenticity and traceability of animal-derived food [6]
    Ye H, Yang J, Xiao G, Zhao Y, Li Z, Bai W, et al. · Food Chem · 2023 · cited 42 times (Europe PMC)
  • Research article Chemometrics for Raman Spectroscopy Harmonization [7]
    Barton B, Thomson J, Lozano Diz E, Portela R · Appl Spectrosc · 2022 · cited 31 times (Europe PMC)
  • Research article Recent Advances in GC×GC and Chemometrics to Address Emerging Challenges in Nontargeted Analysis [8]
    Trinklein TJ, Cain CN, Ochoa GS, Schöneich S, Mikaliunaite L, Synovec RE · Anal Chem · 2023 · cited 23 times (Europe PMC)
  • Research article Chemometric approach in environmental pollution analysis: A critical review [9]
    Inobeme A, Nayak V, Mathew TJ, Okonkwo S, Ekwoba L, Ajai AI, et al. · J Environ Manage · 2022 · cited 22 times (Europe PMC)
  • Research article Successful combination of benchtop nuclear magnetic resonance spectroscopy and chemometric tools: A review [10]
    Galvan D, de Aguiar LM, Bona E, Marini F, Killner MHM · Anal Chim Acta · 2023 · cited 20 times (Europe PMC)

References

  1. Liu J, Xu Y, Liu S, Yu S, Yu Z, Low SS. Application and Progress of Chemometrics in Voltammetric Biosensing. . 2022. PMID 35884297 · DOI · PMC9313226
  2. Bos TS, Boelrijk J, Molenaar SRA, van 't Veer B, Niezen LE, van Herwerden D, et al.. Chemometric Strategies for Fully Automated Interpretive Method Development in Liquid Chromatography. . 2022. PMID 36318471 · DOI · PMC9685588
  3. LaLone V, Aizenshtadt A, Goertz J, Skottvoll FS, Mota MB, You J, et al.. Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging. . 2023. PMID 37159662 · DOI · PMC10162950
  4. Perez-Mon C, Roncone A, Abrahim A, Islam M, Hauk C, Caillet C, et al.. Pharmabiome analyses in tandem with chemometrics can help trace the provenance of falsified medicines: A proof-of-concept study. . 2026. PMID 41274226 · DOI · PMC7618506
  5. Guo S, Popp J, Bocklitz T. Chemometric analysis in Raman spectroscopy from experimental design to machine learning-based modeling. Nat Protoc. 2021. PMID 34741152 · DOI
  6. Ye H, Yang J, Xiao G, Zhao Y, Li Z, Bai W, et al.. A comprehensive overview of emerging techniques and chemometrics for authenticity and traceability of animal-derived food. Food Chem. 2023. PMID 36152561 · DOI
  7. Barton B, Thomson J, Lozano Diz E, Portela R. Chemometrics for Raman Spectroscopy Harmonization. Appl Spectrosc. 2022. PMID 35622984 · DOI
  8. Trinklein TJ, Cain CN, Ochoa GS, Schöneich S, Mikaliunaite L, Synovec RE. Recent Advances in GC×GC and Chemometrics to Address Emerging Challenges in Nontargeted Analysis. Anal Chem. 2023. PMID 36625122 · DOI
  9. Inobeme A, Nayak V, Mathew TJ, Okonkwo S, Ekwoba L, Ajai AI, et al.. Chemometric approach in environmental pollution analysis: A critical review. J Environ Manage. 2022. PMID 35176568 · DOI
  10. Galvan D, de Aguiar LM, Bona E, Marini F, Killner MHM. Successful combination of benchtop nuclear magnetic resonance spectroscopy and chemometric tools: A review. Anal Chim Acta. 2023. PMID 37423658 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Life TablesClinical Research
  • Quality-Adjusted Life YearsClinical Research
  • Risk AssessmentClinical Research
  • Discriminant AnalysisClinical Research
  • Multivariate AnalysisClinical Research
  • Survival AnalysisClinical Research

All 98 articles in Clinical Research →

At a glance

1,158
PubMed records on this heading
100%
published since 2020
52
review articles
0
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Life TablesClinical Research
  • Quality-Adjusted Life YearsClinical Research
  • Risk AssessmentClinical Research
  • Discriminant AnalysisClinical Research
  • Multivariate AnalysisClinical Research

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support